We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SMFT3:BMFBOVESPASmartfit Escola de Ginastica e Danca SA Analysis

Data as of 2026-09-03 - not real-time

R$17.74

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

At BRL 17.74, Smartfit Escola de Ginástica e Dança S.A. shows a bearish moving-average alignment, with shorter averages beneath longer ones. Across the trailing 30 sessions it lost 14.0%. With RSI at 48.3 the momentum picture is neutral, alongside a bullish MACD signal. The recent range runs from support at BRL 16.45 up to resistance at BRL 18.93.
Valuation screens as undervalued, on a P/E of 16.1 with no clean sector comparison available. Analyst price targets sit 75.4% above the current price. Revenue is growing at 21.5% on a 8.5% profit margin. The 5.85% dividend yield looks stretched against payout coverage.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 36.1%, a beta of 0.80 and a maximum drawdown of 38.8%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.

Top Market Events

Smartfit Escola DE Ginastica E Danca SA BSP:SMFT3 reports 22% revenue growth and record margins, while navigating...Seeking Alpha26dSmartfit Escola de Ginástica e Dança S.Seeking Alpha26dSmartfit Escola de Ginástica e Dança S.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 20.31
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Dividend yield of 5.85% looks stretched against payout coverage
  • Trading below the 200-day average of 20.31

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Dividend yield of 5.85% looks stretched against payout coverage
  • Analyst targets imply +75.4% versus the current price
  • Revenue growth of +21.5%

Key Metrics & Analysis

Financial Health

Revenue Growth21.50%
Profit Margin8.53%
P/E Ratio16.1
ROE11.69%
ROA5.98%
Debt/Equity224.30
P/B Ratio1.8
Op. Cash FlowR$2.1B
Free Cash FlowR$-394064384

Technical Analysis

TrendBearish
RSI48.3
SupportR$16.45
ResistanceR$18.93
MA 20R$17.29
MA 50R$18.94
MA 200R$20.31
MACDBullish
VolumeStable
Fear & Greed Index95.86

Valuation

Fair ValueR$55.89
Target PriceR$31.12
Upside/Downside75.40%
GradeUndervalued
TypeBlend
Dividend Yield5.85%

Risk Assessment

Beta0.80
Volatility36.14%
Sector RiskHigh
Reg. RiskLow
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.